scripbox logo
  • right-arrow
  • Mutual Funds
    right-arrow
  • Nippon Life India Asset Management Ltd
    right-arrow
  • Nippon India Pharma Fund Bonus (PIDCW-A)

Formerly Reliance Pharma Bns

Nippon India Pharma Fund Bonus (PIDCW-A)

Nippon India Pharma Fund Bonus (PIDCW-A)

EquitySectoral / Thematic - Pharma And Healthcare

Top Ranked

306.1361

NAV (Jul 27)

16.9%
5 Year CAGR
Scripbox Opinion

Top Ranked

These are the top-ranked funds within sectoral / thematic - pharma and healthcare mutual funds.However, Scripbox does not recommend investing in sectoral / thematic - pharma and healthcare mutual funds.The pharma benchmark index itself has been a material underperformer over an extended time frame.

Contrary to common perception, this category is also characterised by higher volatility.Investing in these funds will require investors to have a unique insight into the specific areas of investment that these funds focus on.In addition the investor will need to have the ability,inclination and expertise to monitor the prospects closely.Investors are therefore better off investing in diversified funds rather than this category.

Scripbox does not recommend investing in the dividend option of a fund because dividends are taxable at a higher rate than withdrawals.

Our analysis of this fundLearn how we rate funds ->

Track Record

17 Years. The fund has an Extended history for analysis and the track record is excellent.

Relative Size

5,447 Cr. Large within the category

Category View

Relatively Poor. The category has a relatively poor investment outlook

Consistency Of Performance

Consistently Good. The fund has performed well consistently over a period of time

Invest in this fund
Explore a better alternative to this fund with a Scripbox plan.
Build Long Term Wealth

Build Long Term Wealth

Invest in a scientifically curated set of equity mutual funds which are best aligned towards achieving any long term objectives you have.

  • graph-icon-gray
    Historical growth rate of 12% per annum
  • graph-icon-gray
    Recommended Duration > 5 years
  • graph-icon-gray
    No Lock-in
  • graph-icon-gray
    Grow Wealth , Retirement , Kid's Education

No single fund can achieve what a plan can. Learn why

info-icon-blue

Scheme Information

Investment Objective

The scheme seeks to achieve its investment objective by investing at least 80% of its net assets in equity/ equity related instruments of the companies in the pharma sector. The Scheme may also invest some portion of the investible funds in equity and equity related securities of companies other than those engaged in pharma sector. The Scheme may also invest some portion of the investible funds in debt and money market instruments.

Low

Low to Moderate

Moderate

Moderately High

High

Very High

risk-indicator-arrow.svg

Very High Risk

Expense Ratio
2 %
Launched (17y ago)
Jun 05, 2004
AUM in Crores
₹ 5,447
ISIN
INF204K01950
Lock-in
No Lock-in
Benchmark
S&P BSE Healthcare TR INR
SIP Minimum
₹ 0
Lumpsum Min.
₹ 5,000
Fund Managers
user-avatar

Kinjal Desai

Fund Manager

user-avatar

Sailesh Raj Bhan

Fund Manager

calculator

Returns Calculator Comparison

of

for

with step up of

InstrumentReturnsTotal CorpusGainsAnnualised %
Mutual Fund70%₹ 965,796 ₹ 233,18411.25%
EPF70% ₹ 900,761 ₹ 168,1498.50%
Property70% ₹ 867,662 ₹ 135,0507.00%
PPF70% ₹ 869,819 ₹ 137,2077.10%
Bank FD70% ₹ 846,471 ₹ 113,8596.00%
Gold70% ₹ 846,471 ₹ 113,8596.00%
Savings Bank70% ₹ 825,950 ₹ 93,3385.00%

Disclaimer: Products compared like fixed deposits may provide fixed guaranteed returns. Mutual Funds investments are subject to market risk, read all scheme related documents carefully before investing. Past performance is not an indicator of future returns.

build-long-item-wealth-img

Build Long Term Wealth

Invest in a scientifically curated set of equity mutual funds which are best aligned towards achieving any long term objectives you have.

  • Inflation beating returns
    Inflation beating returns
  • Grow Wealth , Retirement , Kid's Education
    Grow Wealth , Retirement , Kid's Education
  • One click investing  tracking
    One click investing tracking
comparison

Comparison with Equity Funds

SBI Focused Equity Fund (G)

SBI Focused Equity Fund (G)

Diversified

Recommended

Top Ranked

17 Years

Age

5

Track Record

Aditya Birla Sun Life Focused Equity Fund (G)

Aditya Birla Sun Life Focused Equity Fund (G)

Diversified

Recommended

Top Ranked

16 Years

Age

5

Track Record

UTI Nifty Index Fund (G)

UTI Nifty Index Fund (G)

Index Funds

Recommended

Top Ranked

21 Years

Age

5

Track Record

HDFC Index Nifty 50 fund (G)

HDFC Index Nifty 50 fund (G)

Index Funds

Recommended

Top Ranked

19 Years

Age

5

Track Record

Kotak Bluechip fund (G)

Kotak Bluechip fund (G)

Large Cap

Recommended

Top Ranked

23 Years

Age

5

Track Record

amc-icon

About the AMC

Nippon Life India Asset Management Ltd

Nippon Life India Asset Management Ltd manages assets worth 215,397 crores and was set up on 24 February 1995. It's current offering of mutual fund schemes includes 90 equity,369 debt and 34 hybrid funds.

amc-img

  • tel-amc-about
    022-33031000
  • mail-amc-about
    customer_care@reliancemutual.com
  • Nippon India Liquid Fund (G)

    Nippon India Liquid Fund (G)

    Liquid

    Recommended

    Top Ranked

    ₹ 22,557 Cr

    Fund Size

    5.30%

    3 Year CAGR

    3 Y CAGR

    Nippon India Growth Fund (G)

    Nippon India Growth Fund (G)

    Mid Cap

    Recommended

    Top Ranked

    ₹ 10,261 Cr

    Fund Size

    16.80%

    5 Year CAGR

    5 Y CAGR

    Nippon India Liquid Fund Retail (G)

    Nippon India Liquid Fund Retail (G)

    Liquid

    Top Ranked

    ₹ 22,557 Cr

    Fund Size

    4.60%

    3 Year CAGR

    3 Y CAGR

    Nippon India Growth Fund Inc Dist cum Cap Wdrl (PIDCW-A)

    Nippon India Growth Fund Inc Dist cum Cap Wdrl (PIDCW-A)

    Mid Cap

    Top Ranked

    ₹ 10,261 Cr

    Fund Size

    16.00%

    5 Year CAGR

    5 Y CAGR

    Nippon India Liquid Fund Retail Inc Dist cum Cap Wdrl (D-Q)

    Nippon India Liquid Fund Retail Inc Dist cum Cap Wdrl (D-Q)

    Liquid

    Top Ranked

    ₹ 22,557 Cr

    Fund Size

    3.60%

    3 Year CAGR

    3 Y CAGR

    growth

    Build Long Term Wealth

    Invest in a scientifically curated set of equity mutual funds which are best aligned towards achieving any long term objectives you have.

    • graph-icon-gray
      Historical growth rate of 12% per annum
    • graph-icon-gray
      Recommended Duration > 5 years
    • graph-icon-gray
      No Lock-in
    • graph-icon-gray
      Grow Wealth , Retirement , Kid's Education
    • graph-icon-gray
      One-click investing and tracking
    • graph-icon-gray
      Zero fees for all your investments
    Parag Parikh Flexi Cap fund (Growth)

    Parag Parikh Flexi Cap fund (Growth)

    Equity

    Diversified

    Mirae Asset Large Cap Fund (Growth)

    Mirae Asset Large Cap Fund (Growth)

    Equity

    Large Cap

    Axis Bluechip Fund (Growth)

    Axis Bluechip Fund (Growth)

    Equity

    Large Cap

    Invesco India Growth Opportunities Fund (Growth)

    Invesco India Growth Opportunities Fund (Growth)

    Equity

    Diversified

    How to invest in best mutual funds?

    Investing through Scripbox is made easy and paperless. All you need to do is follow the below steps and start investing.

    01

    Choose a plan

    Choose a plan to invest to start investing

    02

    Create an Account

    Create an account with Scripbox through a paperless process, to invest in this fund.

    03

    Invest online & transfer

    Invest via netbanking, UPI or through an SIP (eNACH mandate).

    04

    Track your investments

    Track, invest more and withdraw your investments through the Scripbox dashboard

    3,600+

    AUM

    2,500+

    Cities

    2012

    Established

    How does Scripbox rate funds?

    Proprietary 4-step system to rate mutual funds

    We use a proprietary system to rate mutual funds and based on that make a recommendation or rate the fund as top ranked.

    What Scripbox recommendations mean?
    Scripbox algorithm recommends 2-4 funds for investment for an investment asset class such as large cap, diversified, liquid etc. When you invest for an objective, the algorithm suggests the appropriate asset class and funds.
    Track Record

    Track Record

    We look at consistent and long historical performance for our analysis.

    Fund Size

    Fund Size

    We look at the size of the fund with respect to other funds in the category. Larger funds are preferred.

    Sub-asset Class View

    Sub-asset Class View

    We check if the sub-category of the fund is recommended by us.

    Fund Performance

    Fund Performance

    Consistency of performance over various tenures is analysed for a relative performance stack.

    Track Record

    Track Record

    We look at consistent and long historical performance for our analysis.

    Fund Size

    Fund Size

    We look at the size of the fund with respect to other funds in the category. Larger funds are preferred.

    Impact of Interest Rates

    Impact of Interest Rates

    We check the relative interest rate risk of the sub-category of the fund. Lower the better.

    Credit Attractiveness

    Credit Attractiveness

    We check the credit quality of the underlying instruments present in the fund. Higher the better.

    Equity Funds

    Debt Funds

    About Nippon India Pharma Fund Bonus (PIDCW-A)

    About Nippon India Pharma Fund Bonus (PIDCW-A)

    Nippon India Pharma Fund Bonus (PIDCW-A) is a sectoral / thematic - pharma and healthcare equity fund and has delivered an annualised return of 22.1% over a period of 17 years .The fund was previously known as Reliance Pharma Bns.The fund is managed by Nippon Life India Asset Management Ltd.The fund managers are Kinjal Desai, Sailesh Raj Bhan

    Nippon India Pharma Fund Bonus (PIDCW-A) Investment Objective

    The scheme seeks to achieve its investment objective by investing at least 80% of its net assets in equity/ equity related instruments of the companies in the pharma sector. The Scheme may also invest some portion of the investible funds in equity and equity related securities of companies other than those engaged in pharma sector. The Scheme may also invest some portion of the investible funds in debt and money market instruments. However, there is no assurance that the objective of the scheme will be realized.

    Nippon India Pharma Fund Bonus (PIDCW-A) NAV,AUM,Risk

    The Nippon India Pharma Fund Bonus (PIDCW-A) fund was launched on Jun 05, 2004. The NAV (Net Asset Value) of this sectoral / thematic - pharma and healthcare equity as of 2021-07-27 is ₹ 306.1361. The total AUM (Asset Under Management) of the fund as of 2021-07-28 is ₹ 5446.948. The category risk of the Nippon India Pharma Fund Bonus (PIDCW-A) fund is Very High Risk. The fund charges 2.0 % as expense ratio.

    Nippon India Pharma Fund Bonus (PIDCW-A) Holdings

    The fund’s highest allocation is towards equity and has invested 99.3% in this asset class. The top three holdings of the fund are dr reddy's laboratories ltd,divi's laboratories ltd and sun pharmaceuticals industries ltd

    Nippon India Pharma Fund Bonus (PIDCW-A) SIP

    The minimum SIP (Systematic Investment Plan) amount for this is ₹ 0 and you can increase this in multiples of ₹ 100. In case you want to invest a lump sum, the minimum amount to be invested is ₹ 5000.

    Nippon India Pharma Fund Bonus (PIDCW-A) Investment volatility and Horizon

    This fund is meant for investors with a minimum investment horizon of 5-7 years. Due to the asset class nature, expect volatility in your investments over the short term. The fund is benchmarked to S&P BSE Healthcare TR INR

    Nippon India Pharma Fund Bonus (PIDCW-A) Review

    Nippon India Pharma Fund Bonus (PIDCW-A) has a score of 4 on a scale of 5. The fund scores 5 out of 5 based on historical performance. As compared to the other funds in its category, Nippon India Pharma Fund Bonus (PIDCW-A) has a score of 4 out of 5. Scipbox has rated this fund 5 out of 5 based on consistency of performance over various years / tenures.

    Get started with investing today

    Invest in the best mutual funds recommended by Scripbox that are algorithmically selected that best suit your needs.

    Build Short Term Wealth

    Build Short Term Wealth

    Beat FD returns with the best debt mutual funds

    Save Taxes, Build Wealth

    Save Taxes, Build Wealth

    Top ELSS funds to save tax the smart way

    Achieve Life Goals

    Achieve Life Goals

    Customised plans for retirement, child education & more

    filter
    Show Calculator